🔗 Visit the ClinicalTrials.gov page for NCT01265433
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. | Cancer Manag Res | 2015 | 1.19 |
| 2 | Trial watch: Peptide vaccines in cancer therapy. | Oncoimmunology | 2012 | 1.17 |
| 3 | New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. | Am J Pathol | 2013 | 1.15 |
| 4 | Novel therapies in phase II and III trials for malignant pleural mesothelioma. | J Natl Compr Canc Netw | 2012 | 0.87 |
| 5 | Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. | Expert Rev Respir Med | 2015 | 0.81 |
| 6 | New roads open up for implementing immunotherapy in mesothelioma. | Clin Dev Immunol | 2012 | 0.80 |
| 7 | Investigational approaches for mesothelioma. | Front Oncol | 2011 | 0.75 |